Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stratified corticosteroid therapy for acute exacerbation of interstitial pneumonia
jRCT1031220450Recruiting
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of prednisolone in interstitial lung disease (ILD), idiopathic interstitial pneumonia (IIP) and idiopathic pulmonary fibrosis (IPF) (3 arms). Started Nov 2022; status: recruiting.
02
Drugs
prednisolone
03
Conditions
interstitial lung disease (ILD)idiopathic interstitial pneumonia (IIP)idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on jRCT1031220450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031220450.